These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 945236)

  • 1. Effect of rifampicin for leprosy: comparative study with several doses and intervals of administration.
    Namba M; Hazama S
    Int J Lepr Other Mycobact Dis; 1976; 44(1-2):198. PubMed ID: 945236
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of probenecid on serum rifampicin levels.
    Pankaj R; Lal S; Rao RS
    Indian J Lepr; 1985; 57(2):329-33. PubMed ID: 4078358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of two multidrug regimens in multibacillary leprosy.
    Jadhav VH; Patki AH; Mehta JM
    Indian J Lepr; 1992; 64(4):501-4. PubMed ID: 1308526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative study of the efficacy of WHO and IAL multidrug therapy regimens for leprosy--an in-vivo and in-vitro study.
    Revankar CR; Mahadevan PR; Ganapati R
    Indian J Lepr; 1986; 58(4):543-8. PubMed ID: 3553361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How effective is monthly rifampin?
    Levy L
    Int J Lepr Other Mycobact Dis; 1993 Dec; 61(4):629-31. PubMed ID: 8151196
    [No Abstract]   [Full Text] [Related]  

  • 6. Drug resistance and multi-drug therapy in leprosy.
    Chatterjee BR
    Indian J Lepr; 1989 Jul; 61(3):328-32. PubMed ID: 2768881
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of multidrug therapy with rifampicin, clofazimine and D.D.S. in multibacillary leprosy cases.
    Kundu SK; Hazra SK; Chaudhury S; Chatterjee B
    Indian J Lepr; 1984; 56(1):78-85. PubMed ID: 6548246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapeutic effect of rifampicin (RFP) on leprosy. I. Clinical effect (observation of twelve months) (author's transl)].
    Repura; 1974; 43(1):8-25. PubMed ID: 4479678
    [No Abstract]   [Full Text] [Related]  

  • 9. Once monthly rifampicin (1200 mg) plus daily dapsone (100 mg) and clofazimine (100 mg) in the initial treatment of lepromatous leprosy.
    Chandorkar AG; Burte NP; Gade RK; Bulakh PM
    Indian J Lepr; 1984; 56(1):63-70. PubMed ID: 6384381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity of rifampin in infections of normal mice with Mycobacterium leprae.
    Grosset JH; Guelpa-Lauras CC
    Int J Lepr Other Mycobact Dis; 1987 Dec; 55(4 Suppl):847-51. PubMed ID: 3437168
    [No Abstract]   [Full Text] [Related]  

  • 11. Comments on an editorial by B. R. Chatterjee "On Multi-Drug Combinations in the Treatment of Leprosy".
    Grosset JH; Baohang J; Noordeen SK
    Indian J Lepr; 1989 Jul; 61(3):323-7. PubMed ID: 2768880
    [No Abstract]   [Full Text] [Related]  

  • 12. [Combined treatments consisting of rifampicin in periodic doses: the experience in Niger].
    Soga G; Blanc L; Alfa C; Grosset J; Xavier S
    Acta Leprol; 1986; 4(4):397-407. PubMed ID: 3296609
    [No Abstract]   [Full Text] [Related]  

  • 13. Study of multidrug therapy in paucibacillary leprosy.
    Kar PK; Sohi AS
    J Indian Med Assoc; 1989 Feb; 87(2):34-6. PubMed ID: 2674283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shortness of breath with urticaria due to once monthly rifampicin.
    Gupta CM; Bhate RD
    Lepr Rev; 1987 Sep; 58(3):308-9. PubMed ID: 2959830
    [No Abstract]   [Full Text] [Related]  

  • 15. Reversible acute renal failure due to monthly administration of rifampicin in a leprosy patient.
    Kar HK; Roy RG
    Indian J Lepr; 1984; 56(4):835-9. PubMed ID: 6549453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapy trial with a triple-drug regimen, including once-monthly Rimactane (Rifampicin), in patients with multibacillary types of leprosy.
    Reyes-Javier PD; Tantiongco PR
    Acta Leprol; 1983; 1(3):133-41. PubMed ID: 6359801
    [No Abstract]   [Full Text] [Related]  

  • 17. [Inadequate rifampicin treatment in multibacillary leprosy and the incubation time of relapse].
    Pattyn SR; Husser JA; Baquillon G; Grillone S; Van Loo G; Bourland J
    Acta Leprol; 1986; 4(3):301-2. PubMed ID: 3551469
    [No Abstract]   [Full Text] [Related]  

  • 18. Paucibacillary leprosy: a comparative study of different schedules of multidrug therapy.
    Ramakrishnan KR; Arora PN; Aggarwal SK; Ramachandra S
    Indian J Lepr; 1988 Oct; 60(4):542-8. PubMed ID: 3253333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapeutic trials with different regimens containing rifampicin in paucibacillary type of leprosy cases--a preliminary report.
    Katoch K; Ramu G; Ramanathan U
    Indian J Lepr; 1985; 57(3):499-506. PubMed ID: 3831087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multidrug therapy for paucibacillary leprosy: WHO regimen inadequate?
    Pavithran K
    Lepr Rev; 1987 Sep; 58(3):306-8. PubMed ID: 3669872
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.